Segarra 2010.

Methods	Allocation: randomised. Blinding: unclear. Setting: not stated. Duration: not stated.
Participants	Diagnosis: schizophrenia, first episode N = 87 Age: not stated Sex: not stated History: not stated Included: not stated Excluded: not stated Consent: not stated
Interventions	1. Risperidone depot, n = 18 2. Oral antipsychotic treatment, n = 21
Outcomes	PAS Scale, neuropsychological battery, diagnostic assessment (SCID‐I) and stability at one year follow‐up, clinical assessment (PANSS; CGI; SUMD; HDRS and YMRS), functional assessment (GAF), quality of life (WHO/DAS), hospitalisations, urgency episodes and treatment compliance
Notes	Unable to extract any usable data from the published conference poster and abstract. Number of total included participants does not match numbers randomised.